Emerging Pharmacologic Treatments for Alcohol- Associated Hepatitis Current Status and Future Landscape

被引:0
|
作者
Morgan, Timothy R. [1 ,2 ]
机构
[1] VA Long Beach Healthcare Syst, Med Serv Gastroenterol, 5901 East Seventh St, Long Beach, CA 90822 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA USA
关键词
Alcohol-associated hepatitis; Interleukin-22; Fecal microbiota transfer; Larsucosterol; Rifaximin; Phage therapy; N-ACETYLCYSTEINE; LIVER-INJURY; MICROBIOTA; CORTICOSTEROIDS; REGENERATION; SURVIVAL; IMPROVES; FAILURE; MODEL;
D O I
10.1016/j.cld.2024.06.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Multiple treatments have shown preliminary efficacy for the treatment of alcoholic hepatitis. These treatments address different pathophysiologic pathways, including hepatocyte regeneration, changing the microbiome, and antioxidants. Many of these approaches use relatively inexpensive treatments that are currently available, although not for alcoholic hepatitis. Other treatments would require support from pharmaceutic companies. Given the burden of AH in many countries, the potential adverse events with corticosteroid treatment (or contraindications to corticosteroids), and the positive preliminary data with several agents, trials of new agents for the treatment of AH are reasonable.
引用
收藏
页码:747 / 760
页数:14
相关论文
共 50 条
  • [31] Current status and future landscape of diagnosing tuberculosis infection
    Kobashi, Yoshihiro
    RESPIRATORY INVESTIGATION, 2023, 61 (05) : 563 - 578
  • [32] The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets
    Chong, Dawn Q.
    Zhu, Andrew X.
    ONCOTARGET, 2016, 7 (29) : 46750 - 46767
  • [33] Current Therapies for Alcohol-Associated Hepatitis
    Maddur, Haripriya
    CLINICS IN LIVER DISEASE, 2021, 25 (03) : 595 - 602
  • [34] Emerging economies multinationals: current status and future prospects
    Salehizadeh, Mehdi
    THIRD WORLD QUARTERLY, 2007, 28 (06) : 1151 - 1166
  • [35] Nanoceuticals as an Emerging Field: Current Status and Future Prospective
    Malik, Reetu
    Rathi, Jyoti
    Manchanda, Deeksha
    Makhija, Manish
    Kushwaha, Deepshikha
    Katiyar, Prashant
    Kaushik, Deepak
    Jalwal, Pawan
    Pandey, Parijat
    Purohit, Deepika
    CURRENT NUTRITION & FOOD SCIENCE, 2021, 17 (07) : 679 - 689
  • [36] Chronic hepatitis B and D (delta). Current and future treatments
    Wortmann, N.
    zu Siederdissen, C. Hoener
    Cornberg, M.
    INTERNIST, 2018, 59 (06): : 519 - 527
  • [37] Demographic inequities exist and influence transplant outcomes in liver transplantation for acute alcohol- associated hepatitis
    Samuel, Sonia
    Choubey, Ankur
    Koizumi, Naoru
    Ekwenna, Obi
    Baxter, Patrick R.
    Li, Meng-Hao
    Malik, Raza
    Ortiz, Jorge
    HPB, 2023, 25 (07) : 845 - 854
  • [38] Treatment of alcohol problems: current status and future directions
    Haber, Paul S.
    Riordan, Benjamin C.
    Morley, Kirsten C.
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 215 (07) : 315 - 316
  • [39] Hepatitis B Current Status of Therapy and Future Therapies
    Spyrou, Elias
    Smith, Coleman, I
    Ghany, Marc G.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (02) : 215 - +
  • [40] Acute Hepatitis C: Current Status and Future Perspectives
    Fasano, Massimo
    Ieva, Francesco
    Ciarallo, Marianna
    Caccianotti, Bruno
    Santantonio, Teresa Antonia
    VIRUSES-BASEL, 2024, 16 (11):